Answers are grounded in this paper and cite their sources.
The pregnancy disorder preeclampsia (PE) is characterized by hypertension and an increase in anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1), a clinical biomarker for PE diagnosis. PE is often accompanied by fetal growth restriction (FGR) and predisposes offspring to programming of diseases in adulthood. It remains unclear whether anti-angiogenesis, independent of FGR, contributes to postnatal metabolic programming. Using a transgenic mouse model, we simulated PE/FGR by systemic human sFLT1 (hsFLT1) overexpression. This allowed us to differentiate the effects of PE from FGR-related consequences by comparison to an FGR-only control group. Further, challenging the offspring after weaning with a high-caloric Western-style diet (WD) compared to a standard diet (SD) revealed PE-specific metabolic programming predominantly in males. Under SD conditions, PE males exhibited increased hepatic AKT and ERK signaling and lacked significant weight gain. PE SD males showed elevated RNA expression of leptin-sensitive Pomc and Slc16a8 in the hypothalamus, suggesting increased leptin sensitivity under these conditions. Only PE WD males developed a metabolic syndrome (obesity, glucose intolerance, elevated serum leptin and triglyceride levels). Furthermore, PE WD males exhibited inflammatory liver damage as evidenced by increased serum alanine aminotransferase (ALT) and hepatic tumor necrosis factor alpha (TNFα) protein levels. Bulk liver RNA sequencing revealed increased inflammation and dysregulated metabolism. The microbiome and stress (serum corticosterone) were excluded as confounders in PE-specific fetal programming. This study highlights the increased risk of male offspring developing a diet-induced metabolic syndrome after hsFLT1 exposure during preeclampsia.
No takes yet. Share an insight, caveat, or question.
Edinger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: